Truist Securities Maintains Hold on Teladoc Health, Raises Price Target to $9

Benzinga · 2d ago
Truist Securities analyst Jailendra Singh maintains Teladoc Health (NYSE:TDOC) with a Hold and raises the price target from $8 to $9.